Virtual treatment planning in three patients with univentricular physiology using computational fluid dynamics-Pitfalls and strategies.
4D flow MRI
Fontan
computational fluid dynamics
computed tomography
decision support
hepatic factor
image-based modeling
univentricular physiology
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
17
03
2022
accepted:
18
07
2022
entrez:
22
8
2022
pubmed:
23
8
2022
medline:
23
8
2022
Statut:
epublish
Résumé
Uneven hepatic venous blood flow distribution (HFD) to the pulmonary arteries is hypothesized to be responsible for the development of intrapulmonary arteriovenous malformations (PAVM) in patients with univentricular physiology. Thus, achieving uniform distribution of hepatic blood flow is considered favorable. However, no established method for the prediction of the post-interventional hemodynamics currently exists. Computational fluid dynamics (CFD) offers the possibility to quantify HFD in patient-specific anatomies before and after virtual treatment. In this study, we evaluated the potential benefit of CFD-assisted treatment planning. Three patients with total cavopulmonary connection (TCPC) and PAVM underwent cardiovascular magnetic resonance imaging (CMR) and computed tomography imaging (CT). Based on this imaging data, the patient-specific anatomy was reconstructed. These patients were considered for surgery or catheter-based intervention aiming at hepatic blood flow re-routing. CFD simulations were then performed for the untreated state as well as for different surgical and interventional treatment options. These treatment options were applied as suggested by treating cardiologists and congenital heart surgeons with longstanding experience in interventional and surgical treatment of patients with univentricular physiology. HFD was quantified for all simulations to identify the most viable treatment decision regarding redistribution of hepatic blood flow. For all three patients, the complex TCPC anatomy could be reconstructed. However, due to the presence of metallic stent implants, hybrid models generated from CT as well as CMR data were required. Numerical simulation of pre-interventional HFD agreed well with angiographic assessment and physiologic considerations. One treatment option resulting in improvement of HFD was identified for each patient. In one patient follow-up data after treatment was available. Here, the virtual treatment simulation and the CMR flow measurements differed by 15%. The combination of modern computational methods as well as imaging methods for assessment of patient-specific anatomy and flow might allow to optimize patient-specific therapy planning in patients with pronounced hepatic flow mismatch and PAVM. In this study, we demonstrate that these methods can also be applied in patients with complex univentricular physiology and extensive prior interventions. However, in those cases, hybrid approaches utilizing information of different image modalities may be required.
Sections du résumé
Background
UNASSIGNED
Uneven hepatic venous blood flow distribution (HFD) to the pulmonary arteries is hypothesized to be responsible for the development of intrapulmonary arteriovenous malformations (PAVM) in patients with univentricular physiology. Thus, achieving uniform distribution of hepatic blood flow is considered favorable. However, no established method for the prediction of the post-interventional hemodynamics currently exists. Computational fluid dynamics (CFD) offers the possibility to quantify HFD in patient-specific anatomies before and after virtual treatment. In this study, we evaluated the potential benefit of CFD-assisted treatment planning.
Materials and methods
UNASSIGNED
Three patients with total cavopulmonary connection (TCPC) and PAVM underwent cardiovascular magnetic resonance imaging (CMR) and computed tomography imaging (CT). Based on this imaging data, the patient-specific anatomy was reconstructed. These patients were considered for surgery or catheter-based intervention aiming at hepatic blood flow re-routing. CFD simulations were then performed for the untreated state as well as for different surgical and interventional treatment options. These treatment options were applied as suggested by treating cardiologists and congenital heart surgeons with longstanding experience in interventional and surgical treatment of patients with univentricular physiology. HFD was quantified for all simulations to identify the most viable treatment decision regarding redistribution of hepatic blood flow.
Results
UNASSIGNED
For all three patients, the complex TCPC anatomy could be reconstructed. However, due to the presence of metallic stent implants, hybrid models generated from CT as well as CMR data were required. Numerical simulation of pre-interventional HFD agreed well with angiographic assessment and physiologic considerations. One treatment option resulting in improvement of HFD was identified for each patient. In one patient follow-up data after treatment was available. Here, the virtual treatment simulation and the CMR flow measurements differed by 15%.
Conclusion
UNASSIGNED
The combination of modern computational methods as well as imaging methods for assessment of patient-specific anatomy and flow might allow to optimize patient-specific therapy planning in patients with pronounced hepatic flow mismatch and PAVM. In this study, we demonstrate that these methods can also be applied in patients with complex univentricular physiology and extensive prior interventions. However, in those cases, hybrid approaches utilizing information of different image modalities may be required.
Identifiants
pubmed: 35990961
doi: 10.3389/fcvm.2022.898701
pmc: PMC9381838
doi:
Types de publication
Journal Article
Langues
eng
Pagination
898701Informations de copyright
Copyright © 2022 Schafstedde, Yevtushenko, Nordmeyer, Kramer, Schleiger, Solowjowa, Berger, Photiadis, Mykychak, Cho, Ovroutski, Kuehne and Brüning.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Thorac Cardiovasc Surg. 2019 Mar;157(3):1146-1155
pubmed: 31264966
Int J Cardiovasc Imaging. 2014 Aug;30(6):1073-84
pubmed: 24899219
Circulation. 2008 Jan 1;117(1):85-92
pubmed: 18071068
World J Pediatr Congenit Heart Surg. 2019 May;10(3):330-337
pubmed: 31084312
Circulation. 1995 Sep 1;92(5):1217-22
pubmed: 7648668
J Thorac Cardiovasc Surg. 2020 Feb;159(2):652-661
pubmed: 31399233
Cardiol Young. 2021 Aug;31(8):1340-1342
pubmed: 33682660
Ann Thorac Surg. 1998 Mar;65(3):848-9
pubmed: 9527235
Expert Rev Cardiovasc Ther. 2014 Jun;12(6):703-13
pubmed: 24758411
Biology (Basel). 2020 Nov 24;9(12):
pubmed: 33255292
Circ Cardiovasc Imaging. 2013 Nov;6(6):1092-101
pubmed: 24254479
J Cardiovasc Transl Res. 2018 Apr;11(2):133-144
pubmed: 29340873
J Thorac Cardiovasc Surg. 2015 Jun;149(6):1524-30
pubmed: 25816952
Ann Thorac Surg. 1995 Apr;59(4):999-1001
pubmed: 7695433
Ann Biomed Eng. 2016 Jan;44(1):174-86
pubmed: 26183962
Prog Pediatr Cardiol. 2010 Dec 1;30(1-2):31-44
pubmed: 25620865
JACC Cardiovasc Imaging. 2009 Aug;2(8):1024-30
pubmed: 19679291
Circulation. 2012 Nov 20;126(21):2511-5; discussion 2515
pubmed: 23169252
Heart. 2020 Mar;106(6):421-426
pubmed: 31857355
Ann Thorac Surg. 2004 Aug;78(2):697-9
pubmed: 15276554
Pediatr Cardiol. 2006 Jul-Aug;27(4):519-22
pubmed: 16830082
Ann Thorac Surg. 2009 Feb;87(2):548-53
pubmed: 19161777
Ann Biomed Eng. 2012 Dec;40(12):2639-51
pubmed: 22777126
J Cardiovasc Transl Res. 2018 Apr;11(2):145-155
pubmed: 29313269
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1734-1742
pubmed: 29361303
Thorax. 1971 May;26(3):240-8
pubmed: 5089489
Circulation. 1985 Sep;72(3):471-9
pubmed: 4017202
J Thorac Cardiovasc Surg. 2011 May;141(5):1170-7
pubmed: 21334010
Pediatr Cardiol. 2001 Jul-Aug;22(4):343-6
pubmed: 11455406
Ann Thorac Surg. 2003 Nov;76(5):1759-66
pubmed: 14602341
Circulation. 2001 Feb 27;103(8):E39-40
pubmed: 11222486
Eur J Cardiothorac Surg. 2021 Dec 27;61(1):54-61
pubmed: 34195822